Interestingly, HCC patients with TRIM25 amplification displayed shortened disease/progression-free survival and overall survival time compared on contrary to those without TRIM25 amplification (Fig. 7h, i). This evidence concerns the gene TRIM25 and hepatocellular carcinoma.